fra-1 gene overexpression has been shown to represent a general event in th
yroid cell transformation irt vitro and in vivo. Moreover, inhibition of FR
A-1 protein synthesis by stable transfection with a fra-1 antisense constru
ct significantly reduces the malignant phenotype of the transformed thyroid
cells, indicating a pivotal role of the fm-l gene product in the process o
f cellular transformation, In the attempt to define the potential use of FR
A-1 protein detection in the diagnosis of thyroid diseases, we analyzed Fra
-1 expression by a combination of immunohistochemistry and reverse transcri
ption-PCR (RT-PCR) assay in 174 samples of thyroid nodules (22 nodular hype
rplasias, 102 follicular adenomas, 34 papillary carcinomas, 12 follicular c
arcinomas, and 4 anaplastic carcinomas) representative of the spectrum of t
hyroid tumor pathology. FRA-1 protein was abundant in all of the carcinoma
samples (50/50, 100%), with an intense staining in the nucleus and the cyto
plasm, Positive staining was also found in most of the adenomas (90 of 102;
88%), but in this case, the staining was restricted to the nucleus, Simila
r results were obtained from the analysis of thyroid goiters; however, the
number of positive cases Is lower than adenomas (8 of 22; 36%); moreover, t
he staining was not observed in all of the cells. Conversely, no FRA-1 prot
ein was detectable in 12 normal thyroid tissue samples used as controls. RT
-PCR analysis confirmed a higher fra-1 expression in papillary and follicul
ar carcinomas compared with goiters and adenomas, fra-1 expression was also
analyzed on 10 fine needle aspiration biopsy (FNAB) samples ba RT-PCR, fm-
l-specific mRNA was detected in seven of the eight FNABs corresponding to t
hyroid nodules that were eventually diagnosed as adenomas (three of four) a
nd carcinomas (four of four) after surgery. Conversely, no fra-1 gene expre
ssion was observed in two FNABs derived from normal thyroid, Further studie
s are required before suggesting FRA-1 protein detection as a useful tool f
or the diagnosis of hyperplastic and neoplastic disorders of the thyroid gl
and.